TrialThe Permanente journal2020

High Remission Rate with Infliximab and Plant-Based Diet as First-Line (IPF) Therapy for Severe Ulcerative Colitis: Single-Group Trial.

Mitsuro Chiba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.